182 related articles for article (PubMed ID: 14670979)
1. Role of prostaglandin E receptor EP1 subtype in the development of renal injury in genetically hypertensive rats.
Suganami T; Mori K; Tanaka I; Mukoyama M; Sugawara A; Makino H; Muro S; Yahata K; Ohuchida S; Maruyama T; Narumiya S; Nakao K
Hypertension; 2003 Dec; 42(6):1183-90. PubMed ID: 14670979
[TBL] [Abstract][Full Text] [Related]
2. Altered growth response to prostaglandin E2 and its receptor signaling in mesangial cells from stroke-prone spontaneously hypertensive rats.
Suganami T; Tanaka I; Mukoyama M; Kotani M; Muro S; Mori K; Goto M; Ishibashi R; Kasahara M; Yahata K; Makino H; Sugawara A; Nakao K
J Hypertens; 2001 Jun; 19(6):1095-103. PubMed ID: 11403359
[TBL] [Abstract][Full Text] [Related]
3. Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist.
Makino H; Tanaka I; Mukoyama M; Sugawara A; Mori K; Muro S; Suganami T; Yahata K; Ishibashi R; Ohuchida S; Maruyama T; Narumiya S; Nakao K
J Am Soc Nephrol; 2002 Jul; 13(7):1757-65. PubMed ID: 12089371
[TBL] [Abstract][Full Text] [Related]
4. Preventative and therapeutic effects of AE0047 on renal injury in stroke-prone spontaneously hypertensive rats.
Hayashi K; Koyama M; Kido H; Egi Y; Kubo Y; Shinyama H; Iwamoto M; Nakamura N; Kagitani Y
Clin Exp Pharmacol Physiol; 1997 Nov; 24(11):831-40. PubMed ID: 9363365
[TBL] [Abstract][Full Text] [Related]
5. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.
Guan Y; Zhang Y; Wu J; Qi Z; Yang G; Dou D; Gao Y; Chen L; Zhang X; Davis LS; Wei M; Fan X; Carmosino M; Hao C; Imig JD; Breyer RM; Breyer MD
J Clin Invest; 2007 Sep; 117(9):2496-505. PubMed ID: 17710229
[TBL] [Abstract][Full Text] [Related]
7. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
[TBL] [Abstract][Full Text] [Related]
8. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
Knight S; Johns EJ
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
[TBL] [Abstract][Full Text] [Related]
9. Nicorandil ameliorated hypertensive renal injury without lowering blood pressure in spontaneously hypertensive rats.
Serizawa K; Yogo K; Tashiro Y; Koike N; Aizawa K; Hirata M; Ishizuka N
Pharmacology; 2013; 91(1-2):92-103. PubMed ID: 23306764
[TBL] [Abstract][Full Text] [Related]
10. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall.
Sironi L; Gelosa P; Guerrini U; Banfi C; Crippa V; Brioschi M; Gianazza E; Nobili E; Gianella A; de Gasparo M; Tremoli E
J Pharmacol Exp Ther; 2004 Dec; 311(3):989-95. PubMed ID: 15302895
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 expression and phenotypic modulation in the kidney of hypertensive rats.
Hamaguchi A; Kim S; Ohta K; Yagi K; Yukimura T; Miura K; Fukuda T; Iwao H
Hypertension; 1995 Jul; 26(1):199-207. PubMed ID: 7541781
[TBL] [Abstract][Full Text] [Related]
13. The antiproteinuric action of enalapril in stroke-prone spontaneously hypertensive rats is unrelated to alterations in urinary prostaglandins.
Stier CT; Mahboubi K; DiPippo VA; Levine S; Chander PN
J Pharmacol Exp Ther; 1992 Mar; 260(3):1410-5. PubMed ID: 1545401
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha upregulates the prostaglandin E2 EP1 receptor subtype and the cyclooxygenase-2 isoform in cultured amnion WISH cells.
Spaziani EP; Benoit RR; Tsibris JC; Gould SF; O'Brien WF
J Interferon Cytokine Res; 1998 Dec; 18(12):1039-44. PubMed ID: 9877447
[TBL] [Abstract][Full Text] [Related]
15. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
[TBL] [Abstract][Full Text] [Related]
16. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
[TBL] [Abstract][Full Text] [Related]
17. Effects of a selective endothelin A-receptor antagonist, BQ-123, in salt-loaded stroke-prone spontaneously hypertensive rats.
Okada M; Kobayashi M; Maruyama H; Takahashi R; Ikemoto F; Yano M; Nishikibe M
Clin Exp Pharmacol Physiol; 1995 Oct; 22(10):763-8. PubMed ID: 8575114
[TBL] [Abstract][Full Text] [Related]
18. Chronic anti-Thy-1 nephritis is aggravated in the nonclipped but not in the clipped kidney of Goldblatt hypertensive rats.
Wenzel UO; Wolf G; Jacob I; Thaiss F; Helmchen U; Stahl RA
Kidney Int; 2002 Jun; 61(6):2119-31. PubMed ID: 12028452
[TBL] [Abstract][Full Text] [Related]
19. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats.
Rocha R; Chander PN; Zuckerman A; Stier CT
Hypertension; 1999 Jan; 33(1 Pt 2):232-7. PubMed ID: 9931110
[TBL] [Abstract][Full Text] [Related]
20. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes.
Matsuoka Y; Furuyashiki T; Bito H; Ushikubi F; Tanaka Y; Kobayashi T; Muro S; Satoh N; Kayahara T; Higashi M; Mizoguchi A; Shichi H; Fukuda Y; Nakao K; Narumiya S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4132-7. PubMed ID: 12642666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
